Ceribell

CeribellCeribell
Ceribell

Ceribell

AI-powered EEG device for rapid seizure detection in critical care.

DR 502014Active397Sunnyvale, United States
Rate

About

Ceribell is a medical technology company that developed an AI-powered electroencephalogram (EEG) system designed for rapid and accurate seizure detection in hospital settings. Their system aims to provide clinicians with faster insights into brain activity, improving patient care and outcomes in critical situations.
Frequently asked

What does Ceribell do?

Ceribell is a medical technology company that developed an AI-powered electroencephalogram (EEG) system designed for rapid and accurate seizure detection in hospital settings. Their system aims to provide clinicians with faster insights into brain activity, improving patient care and outcomes in critical situations.

What is Ceribell's revenue?

StartupHub estimates Ceribell's annual revenue at $164.1M (range $100.5M to $306.2M, 63% confidence), based on comparable companies in the sector.

What is Ceribell's valuation?

StartupHub estimates Ceribell's effective valuation at $4.2M (range $2.5M to $6.0M, 10% confidence), based on comparable companies in the sector.

How much funding has Ceribell raised?

Ceribell has raised a total of $1M in funding. The most recent round on record is Seed.

Where is Ceribell headquartered?

Ceribell is headquartered in Sunnyvale, United States.

When was Ceribell founded?

Ceribell was founded in 2014.

What industry does Ceribell operate in?

Ceribell operates in MedTech, HealthTech, AI-Driven Protein Design, Clinical Trials, Digital Twin Healthcare, AI Infrastructure.

How many employees does Ceribell have?

Ceribell has approximately 397 people on record.

HEADCOUNT
397
DOMAIN RATING
50
Comments

No comments yet. Be the first to share your take.